Rett syndrome Archives
Dec. 6, 2021—A potential first-of-its-kind drug to treat the symptoms of Rett syndrome received positive top-line results from a phase 3 trial led by investigators from Vanderbilt University Medical Center to evaluate efficacy and safety.
Aug. 24, 2017—Vanderbilt University research-ers have relieved symptoms of Rett syndrome in a mouse model with a small molecule that works like the dimmer switch in an electrical circuit.
Dec. 13, 2016—Jeffrey Neul, M.D., Ph.D., division head of Child Neurology and vice chair for Developmental Neurosciences at the University of California, San Diego, will present a lecture on Friday, Dec. 16, at Vanderbilt Kennedy Center (VKC).
Nov. 17, 2016—Vanderbilt’s Rett Syndrome Clinic has been named a Rett Syndrome Clinical Research Center of Excellence by Rettsyndrome.org.
Apr. 14, 2016—Huda Zoghbi, M.D., recipient of the 2015 Vanderbilt Prize in Biomedical Science, will deliver her Vanderbilt Prize Lecture on Thursday, April 21.
Mar. 3, 2016—Researchers at Vanderbilt University Medical Center have relieved symptoms in a mouse model of Rett syndrome with a drug-like compound that works like the dimmer switch in an electrical circuit.
Jan. 23, 2014—Colleen Niswender, Ph.D., research associate professor of Pharmacology, has received a three-year, $450,000 grant from the autism science and advocacy organization Autism Speaks to support studies investigating a possible new treatment for Rett syndrome.